An analysis of pediatric accelerated approvals from 2000 to 2020 found limited enrollment of children, frequent reliance on adult data, and lengthy delays in confirming benefits.
Children’s Drugs Given FDA Accelerated Approval Relied on a Median of 13 Kids, and Full Approval Took Years
by | Nov 5, 2026 | Uncategorized | 0 comments
Recent Comments